Literature DB >> 6100668

Recombinant vaccinia viruses as new live vaccines.

G L Smith, M Mackett, B Moss.   

Abstract

Mesh:

Substances:

Year:  1984        PMID: 6100668     DOI: 10.1080/02648725.1984.10647806

Source DB:  PubMed          Journal:  Biotechnol Genet Eng Rev        ISSN: 0264-8725


× No keyword cloud information.
  6 in total

1.  Amino-terminal domain of NF1 binds to DNA as a dimer and activates adenovirus DNA replication.

Authors:  F Gounari; R De Francesco; J Schmitt; P van der Vliet; R Cortese; H Stunnenberg
Journal:  EMBO J       Date:  1990-02       Impact factor: 11.598

2.  Conserved TAAAT motif in vaccinia virus late promoters: overlapping TATA box and site of transcription initiation.

Authors:  M Hänggi; W Bannwarth; H G Stunnenberg
Journal:  EMBO J       Date:  1986-05       Impact factor: 11.598

3.  Serro 2 Virus Highlights the Fundamental Genomic and Biological Features of a Natural Vaccinia Virus Infecting Humans.

Authors:  Giliane de Souza Trindade; Ginny L Emerson; Scott Sammons; Michael Frace; Dhwani Govil; Bruno Eduardo Fernandes Mota; Jônatas Santos Abrahão; Felipe Lopes de Assis; Melissa Olsen-Rasmussen; Cynthia S Goldsmith; Yu Li; Darin Carroll; Flavio Guimarães da Fonseca; Erna Kroon; Inger K Damon
Journal:  Viruses       Date:  2016-12-10       Impact factor: 5.048

4.  Increased attenuation but decreased immunogenicity by deletion of multiple vaccinia virus immunomodulators.

Authors:  Rebecca P Sumner; Hongwei Ren; Brian J Ferguson; Geoffrey L Smith
Journal:  Vaccine       Date:  2016-08-17       Impact factor: 3.641

5.  Genomic Characterization of Orf Virus Strain D1701-V (Parapoxvirus) and Development of Novel Sites for Multiple Transgene Expression.

Authors:  Hanns-Joachim Rziha; Mathias Büttner; Melanie Müller; Ferdinand Salomon; Alena Reguzova; Dominic Laible; Ralf Amann
Journal:  Viruses       Date:  2019-01-30       Impact factor: 5.048

6.  Discontinuous transcription or RNA processing of vaccinia virus late messengers results in a 5' poly(A) leader.

Authors:  B Schwer; P Visca; J C Vos; H G Stunnenberg
Journal:  Cell       Date:  1987-07-17       Impact factor: 41.582

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.